维普中文期刊产品整合服务
12篇 您的检索式:期刊名="AATEX"
    题名 作者 年代 出处 被引量
1BALB/c 3T3 cell transformation assays for the assessment of chemical carcinogenicity显示文摘Sakai A 2007AATEX2007,14,:1
2Balb/c 3T3 cell transformation assays for the assessment of chemical carcinogenicity显示文摘SAKAI A 2007AATEX2007,14,:1
3Liver ceils culture on three- dimensional micropatterned polydimethylsiloxane Surfaces 显示文摘EVENOU F FUJII T SAKAI Y 2008AATEX2008,14,:1
4Bhas42 cell transformation assay as a predictor of carcinogenicity显示文摘POTH A HEPPENHEIMER A BOHNENBERGER S 2007AATEX2007,,:1
5A clinically rele- vant in vitro pyrogen test using a human cell line that have the similar responsiveness to various pyrogens to that of hu man peripheral blood cells (hPBC) 显示文摘Akiniko Y Masaki O Kazunari K 2007AATEX2007,14,:1
6Making validated alternatives available - the strategies and work of the European centre for the validation of alternative methods (ECVAM) 显示文摘Zuang V Hartung T 2005AATEX2005,11,:1
7Comparison of human skin irritaiton and photo-irritation patch test data with cellular in vitro assays and animal in vivo data显示文摘JIROVA D LIEBSCH M BASKETTER D 2008AATEX2008,14,:1
8Development of a modified local lymph node assay using ATP measurement as an endpoint显示文摘YAMASHITA K IDEI-IARA K F UKADA N 2005AATEX2005,11,:1
9Validation of alternative endpoints for the LLNA: generalconsiderations 显示文摘Casati S 2007AATEX2007,14,:1
10Validation of alternative endpoints for the LLNA: General considerations 显示文摘SILVIA C 2007AATEX2007,14,:1
11Balb-c 3T3 cell transformat ion assays for the assessment of chemical carcinogenicity 显示文摘SAKAI A 2007AATEX2007,14,:1
12A clinically relevant in vitro pyrogen test using a human cell line that have the similar respon- siveness to various pyrogens to that of human peripheral blood cells (hPBC) 显示文摘Yamamoto A Ochiai M Kamachi K 2007AATEX2007,14,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费